跳至主要内容
临床试验/NCT03879434
NCT03879434已完成不适用

Routine Application of Ostenil® Mini in Patients With Rhizarthrosis

TRB Chemedica AG6 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年4月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
6
主要终点
Incidence of Treatment-Emergent Adverse Events

研究概览

简要总结

PMCF study to observe the routine application of Ostenil® Mini in the treatment of pain and restricted mobility in degenerative and traumatic changes of the CMC joint.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects ≥ 18 years of age and in good general health condition
  • Signed informed consent
  • Existing Ostenil® Mini recommendation for the treatment of rhizarthrosis

排除标准

  • Known hypersensitivity to one of the Ostenil® Mini components
  • Known pregnancy or lactating females
  • Presence of coagulation disorder
  • Subjects not capable of contracting and of understanding the nature, risks, significance and implications of the clinical investigation and unable to form a rational intention in the light of these facts
  • Subjects unable to understand informed consent or having a high probability of non compliance to the study procedures and / or non completion of the study according to investigator's judgement (e.g. illiteracy, insufficient knowledge of local language)

结局指标

主要结局

Incidence of Treatment-Emergent Adverse Events

时间窗: Up to Day 252 after the last injection

Change of Tip Pinch Strength compared to Baseline (Pinch Gauge)

时间窗: Day 7, Day 14, Day 84 after last injection, Day 168 after last injection

Measurement of Tip Pinch in kilograms with a Pinch Gauge

Change of Palmar Pinch Strength compared to Baseline (Pinch Gauge)

时间窗: Day 7, Day 14, Day 84 after last injection, Day 168 after last injection

Measurement of Palmar Pinch in kilograms with a Pinch Gauge

Change of Subjective Therapy Evaluation (FIHOA Questionnaire, 4 grade scale) compared to Baseline

时间窗: Day 7, Day 14, Day 84 after last injection, Day 168 after last injection

Functional Index for Hand OsteoArthritis (FIHOA) to assess hand-OA related functional impairment on a 4-grade scale

Change of Pain Intensity compared to Baseline (VAS-slider)

时间窗: Day 7, Day 14, Day 84 after last injection, Day 168 after last injection

Evaluation of Pain Intensity by the Patient on a 10 cm VAS-slider. (10 cm equal the worst pain)

Change of Subjective Quality of Life Evaluation (Questionnaire with 5 Point Likert scale) compared to Baseline

时间窗: Day 7, Day 14, Day 84 after last injection, Day 168 after last injection

Questionnaire to assess hand-OA related Quality of Life on a 5-grade scale

Change of Subjective Symptom Evaluation (Overall Impression on a scale from 1 to 5)

时间窗: Day 7, Day 14, Day 84 after last injection, Day 168 after last injection

The Change of Overall Subjective Symptom Evaluation on a scale from 1 (much improved) to 5 (much worse)

Change of Key Pinch Strength compared to Baseline (Pinch Gauge)

时间窗: Day 7, Day 14, Day 84 after last injection, Day 168 after last injection

Measurement of Key Pinch in kilograms with a Pinch Gauge

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Routine Application of Ostenil® Mini in Patients... | 临床试验